Lucira Health Makes Progress with STI Panel, Prepares Rollout of Digital Health Platform
If commercialized, the assay will mark Lucira's entry into market for at-home diagnostics for sexually transmitted infections.
Stay updated with breaking news from Debkishore Mitra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
If commercialized, the assay will mark Lucira's entry into market for at-home diagnostics for sexually transmitted infections.
Study Reveals Lucira’s Testing Assays Offer a 98% Accuracy Rate in Detecting Both Sexually Transmitted InfectionsEMERYVILLE, Calif., Sept. 29, 2022 -- Lucira Health, Inc. , a medical... | September 29, 2022
While most people are familiar with rapid at-home antigen tests, Cue Health, Detect, and Lucira Health all have FDA-authorized OTC molecular tests that combine PCR accuracy with the convenience of at-home antigen tests.
/PRNewswire/ -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization...